THURSDAY, MAY 20, 2010
|
8:30 Registration
9:00 Jacques Young, Paris, France : Introduction
|
SESSION 1 Basic
|
Chairs : Najiba Lahlou, Alain Gougeon
9:10 Alain Gougeon, Lyon, France
Ovarian follicular developpment in primates : facts and hypotheses.
9:30 Marco Conti, Stanford, USA
Cyclic AMP and meiotic arrest in mammalian oocytes.
10:00 Martin M. Matzuk, Houston, USA
Oocyte-somatic cell communication and microRNA function in the ovary.
10:30 Jenny Visser, Rotterdam, Netherlands
AMH : marker and regulator of ovarian function.
11:00-11:30 Coffee break
|
| SESSION 2 GnRH-Gonadotrophin-ovarian axis
|
Chairs : Anne Bachelot, Catherine Dodé
11:30 Jean Pierre Hardelin, Paris, France
Genetic control of GnRH neurons ontogenesis.
11:50 William H. Colledge, Cambridge, UK
The role of kisspeptin signalling in the regulation of the GnRH-gonadotrophin ovarian axis in mice.
12:20 Manuel Tena-Sempere, Cordoba, Spain
KiSS-1/kisspeptins and the metabolic control of reproduction : physiologic roles and physiopathological implications.
12:50-14:15 Lunch (free)
14:15 Jacques Young, Paris, France
Congenital hypogonadotropic hypogonadism in women : the clinical spectrum and genetics.
14:35 Alessandro D. Genazzani, Modena, Italy
Functionnal hypothalamic amenorrhea.
|
| SESSION 3 From mice models to human diseases |
Chairs : Nadine Binart, Yves Morel
15:00 Ilpo Huhtaniemi, London, UK
Ovarian consequences of gonadotropin and gonadotropin receptor genetic manipulations in mice.
15:30-16:10 Coffee break – Poster Session
16:10 Philippe Touraine, Paris, France
Genotype/phenotype relationship of gonadotropin receptor mutations in women.
16:35 Patrice Rodien, Angers, France
Ovarian hyperstimulation syndrome due to mutations in the Follicle-Stimulating Hormone Receptor.
17:00 Philippe Chanson, Paris, France
Ovarian dysfunction due to Gas activation: the McCune Albright model
End of the day 17:25
|
FRIDAY, MAY 21, 2010
|
| SESSION 4 Premature ovarian failure |
Chairs : Philippe Touraine, Anne Guiochon-Mantel
9:00 Gerard Conway, London, UK
Premature ovarian failure and FMR1 gene mutations : an update.
9:25 Elfride De Baere, Ghent, Belgium
Role of FOXL2 impairment in syndromic and non-syndromic POF.
9:50 Anu Bashamboo, Paris, France
Mutations in NR5A1/SF1 and ovarian insufficiency.
10:15 Sophie Christin-Maitre, Paris, France
Genome-wide association scans and identification of news susceptibility loci for premature ovarian failure.
10:40-11:10 Coffee break – Poster session
|
| SESSION 5 PCOS: pathophysiology and treatment |
Chairs : Anne Caufriez, Michel Pugeat
11:10 Paolo Beck-Peccoz, Milan, Italy
PCOS : unresolved issues and new questions.
11:30 Corinne Vigouroux, Paris, France
What have we learned form monogenic forms of PCOS/HAIRAN associated with severe insulin resistance.
11:50 Stephen Franks, London, UK
Follicle dynamics and anovulation in polycystic ovary syndrome.
12:20 Didier Dewailly, Lille, France
Which morphological investigations and how to interpret them to make the diagnosis of PCOS.
12:40 Philippe Bouchard, Paris, France
PCOS and ovulation induction, an up to date of different medical approchaes.
13:10-14:10 Lunch (free)
|
| SESSION 6 New therapeutic approaches in ovarian pathology |
Chairs : René Frydman, Catherine Poirot
14:10 Nadine Binart, Paris, France
Immature cryopreserved ovary transplantation in mice : efficacy and epigenetic marks.
14:40 Jacques Donnez, Brussels, Belgium
Restoration of ovarian function by transplanted cryopreserved ovarian tissue in women.
15:10 Helen Picton, Leeds, UK
The in vitro growth and maturation of ovarian follicles-the facts and the future.
15:40 Yves Le Bouc, Paris, France
Is medical assisted reproduction devoid of epigenetic risk ?
16:10 Philippe Bouchard, Paris, France : Conclusion
16:25 End of the symposium |
|
